Alternative To Oxford-AstraZeneca Vaccine

Capt. John

AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine has recently dominated headlines after cases of rare blood clots were reported in European countries. Now, European Medical Agency (EMA) is investigating potential clotting risks from Johnson & Johnson’s (NYSE: JNJ) one-shot COVID-19 vaccine, reports Yahoo Finance.

What Happened?

While AstraZeneca has been caught in a frenzy over possible links to rare blood clots and subsequent restriction on the usage of its vaccine, this is a formal disclosure...

https://mfame.guru/alternative-to-oxford-astrazeneca-vaccine/

Leave a Comment

Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.
icon